Higher defibrillation threshold in methamphetamine cardiomyopathy patients with implantable cardioverter-defibrillator [PDF]
Indian Pacing and Electrophysiology Journal, 2017 Introduction: Identification of patients with an increased risk of high defibrillation thresholds (DFTs) is important in planning implantable cardioverter-defibrillator (ICD) procedures.
Rakesh Malhotra +3 more
doaj +6 more sources
Subcutaneous ICD lead position affects defibrillation threshold [PDF]
HeartRhythm Case Reports, 2018 Hariharan Sugumar, MBBS, BMedSci +4 more
doaj +7 more sources
Defibrillation Threshold Testing: Current Status. [PDF]
Arrhythm Electrophysiol Rev, 2018 When the transvenous ICD initially came into use for primary and secondary prevention of sudden cardiac death, defibrillation threshold (DFT) testing was universally performed.
Hayase J, Do DH, Boyle NG.
europepmc +4 more sources
Subcutaneous Implantable Cardioverter Defibrillators Implantation Without Defibrillation Threshold Testing: A Single Center Experience. [PDF]
Cardiol Res, 2017 Background Subcutaneous implantable cardioverter defibrillator (S-ICD) system has been proven to be an effective therapy for prevention of sudden cardiac death (SCD) in selected patients. Although the Shockless IMPLant Evaluation (SIMPLE) trial has shown
Al-Ghamdi B +5 more
europepmc +4 more sources
Heart defibrillation: relationship between pacing threshold and defibrillation probability [PDF]
BioMedical Engineering OnLine, 2019 Background Considering the clinical importance of the ventricular fibrillation and that the most used therapy to reverse it has a critical side effect on the cardiac tissue, it is desirable to optimize defibrillation parameters to increase its efficiency.
Priscila C. Antoneli +4 more
doaj +4 more sources
High defibrillation threshold with a subcutaneous implantable cardiac defibrillator due to the lead having been positioned in the fat layer [PDF]
Journal of Arrhythmia, 2018 A 46‐year‐old female with a body mass index of 38.9 kg/m2 and no organic heart disease underwent a subcutaneous implantable cardioverter‐defibrillator implantation for secondary prevention of sudden cardiac death in the setting of idiopathic ventricular ...
Tatsuhiko Hirao +5 more
doaj +3 more sources
Usefulness of lead repositioning from left to right sternal border for a patient with subcutaneous implantable cardioverter defibrillator showing high defibrillation threshold [PDF]
Journal of Arrhythmia, 2019 A 62‐year‐old man with Brugada syndrome underwent subcutaneous implantable cardioverter defibrillator implantation. The lead was positioned along the left sternal border and defibrillation threshold (DFT) testing was performed.
Yasushi Wakabayashi +3 more
doaj +4 more sources
Shoulder Joint Dislocation as an Unusual Complication of Defibrillation Threshold Testing Following Subcutaneous Implantable Cardioverter-Defibrillator Implantation [PDF]
Indian Pacing and Electrophysiology Journal, 2014 A 53-year-old man underwent implantation of a totally subcutaneous ICD (S-ICD; Boston Scientific). He was positioned supine, with the left arm abducted, externally rotated (i.e. palm up) and strapped to the arm extender.
Amit Noheria, MBBS, SM +3 more
doaj +3 more sources
Unheralded failure of Riata defibrillator lead identified at defibrillation threshold testing
Journal of Arrhythmia, 2013 Background: St Jude Medical “Riata” implantable cardioverter-defibrillator leads have a higher-than-expected failure rate and carry a Class 1 recall.
Matthew R. Webber, MB ChB, FRACP +2 more
doaj +3 more sources
Additional coils mitigate elevated defibrillation threshold in right-sided implantable cardioverter defibrillator generator placement: a simulation study. [PDF]
Europace, 2023 Aims The standard implantable cardioverter defibrillator (ICD) generator (can) is placed in the left pectoral area; however, in certain circumstances, right-sided cans may be required which may increase defibrillation threshold (DFT) due to suboptimal ...
Qian S +9 more
europepmc +2 more sources